approved EB-2 (NIW)

Postdoctoral Research Fellow

Biotechnologies · Venezuela · 2023-02-22

Processing Time
44 days
Decision Date
2023-02-22
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting to determine molecular mechanisms of various health conditions like inflammatory cardiovascular diseases. The work aims to develop novel treatments and create new ways to screen for patient receptiveness to immunotherapy, reducing the reliance on chemotherapy.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research directly addresses cardiovascular disease, a leading cause of death in the U.S. costing $300 billion annually.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of experience, 11 publications, and 179 citations, showing a track record of success.

3 Waiver of Job Offer and Labor Certification Met

The benefits of the petitioner's research into life-saving treatments outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on 11 peer-reviewed journal articles (5 first-authored) and 179 citations, demonstrating significant influence in the field. The case was supported by 4 expert letters and evidence of 8 years of research experience, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Healthcare · Iran

WeGreened EB-2 (NIW) approved
USA 141 days 2025-04-03
The petitioner proposes to investigate the molecular mechanisms underlying cardiovascular diseases to translate these insights into new pharmaceutical therapies. The work involves conducting research within U.S. academic environments to develop treatment paths that minimize invasive procedures and improve cardiovascular outcomes.

Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
88 days 2022-04-01
The petitioner proposes to develop disease transmission models and identify disease-related gene loci to perform in-depth studies on widespread diseases such as heart disease and cancer. Her work aims to provide frameworks for more effective disease control policies and clinical strategies to improve patient outcomes.

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 44 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist